28 December 2023 : Case report
IgA Vasculitis as a Potential Complication of Fourth-Line Chemotherapy with Tegafur/Gimeracil/Oteracil (S-1) in Advanced Non-Small Cell Lung Cancer: A Case Report
Rare coexistence of disease or pathology
Ryotaro Yoneoka1ABCDEF, Hajime Kasai234ABCDEF*, Aoi Hino2ABCDE, Ayumi Hayashi5BCDE, Atsushi Sasaki2BCDE, Masayuki Ota6BCDE, Katsuhiko Asanuma5DE, Takuji Suzuki2DEDOI: 10.12659/AJCR.941826
Am J Case Rep 2023; 24:e941826
Figure 1. (A) Chest radiograph obtained at the first visit to our department revealed a mass extending into the left upper and middle lung field. (B) Upon administration of tegafur/gimeracil/oteracil (S-1) as fourth-line chemotherapy, the mass appeared reduced in size on the chest radiograph, compared with its appearance before chemotherapy. (C) At the time of the appearance of purpura, the tumor was once again enlarged despite treatment with 7 courses of S-1.